Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDAGet Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

Shares of NASDAQ RKDA opened at $5.92 on Thursday. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The firm has a market cap of $8.08 million, a price-to-earnings ratio of -1.38 and a beta of 1.19. The stock’s 50-day simple moving average is $4.54 and its 200-day simple moving average is $3.49.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Read More

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.